OCGN Ocugen, Inc.
Ocugen, Inc. (OCGN) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $525.0K.
Where they traded
Last open-market purchase: June 15, 2026 , by Johnson-Greene Treerita Essalima .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Musunuri Shankar 2 fills | Chief Executive Officer | Sell 10b5-1 | 525,991 | $1.12 | $589.1K | 4,487,197 −10.5% of holding | |
| Johnson-Greene Treerita Essalima | Chief Financial Officer | Buy | 21,000 | $1.23 | $25.8K | 521,000 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.